Mader & Shannon Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-35,547
Closed -$7.16M 17
2022
Q2
$7.16M Sell
35,547
-521
-1% -$111K 4.28% 6
2022
Q1
$8.17M Buy
36,068
+1,440
+4% +$339K 4.43% 5
2021
Q4
$9.35M Buy
34,628
+484
+1% +$120K 5.17% 4
2021
Q3
$8.26M Buy
34,144
+10
+0% +$2.52K 5.27% 4
2021
Q2
$8.09M Buy
34,134
+215
+0.6% +$49K 4.17% 5
2021
Q1
$7.43M Buy
33,919
+718
+2% +$144K 4.35% 5
2020
Q4
$5.81M Buy
+33,201
New +$5.73M 3.85% 8
2018
Q1
Sell
-23,959
Closed -$3.28M 18
2017
Q4
$3.28M Buy
23,959
+751
+3% +$99.2K 2.4% 17
2017
Q3
$3.01M Buy
+23,208
New +$3.1M 1.93% 17

Other funds holding LH

Mader & Shannon Wealth Management's LH Position: Q3 2022 in Review

Mader & Shannon Wealth Management sold out of Labcorp (LH) in Q3 2022, closing a stake of 35,547 shares — an estimated $7.16M sold.

Mader & Shannon Wealth Management first reported a position in LH in Q3 2017 and held it in 9 quarters. The position peaked at $9.35M in Q4 2021. 937 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Mader & Shannon Wealth Management reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
  • Mader & Shannon Wealth Management sold 35,547 Labcorp shares in Q3 2022, an estimated $7.16M.
  • Mader & Shannon Wealth Management first reported a position in Labcorp in Q3 2017 and held it in 9 quarters.
  • Mader & Shannon Wealth Management's Labcorp position peaked at $9.35M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Mader & Shannon Wealth Management's 13F filing for Q3 2022, filed 27 Oct 2022.